Y-mAbs Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 4.24 M | $18.77 M | 0.00% | 9.39% |
05/19/2025 | 3.24 M | $14.33 M | 13.05% | 7.17% | |
BLACKROCK, INC. | 05/02/2025 | 2.90 M | $12.86 M | -3.22% | 6.43% |
CALIGAN PARTNERS LP | 05/15/2025 | 2.34 M | $10.38 M | 32.50% | 5.19% |
SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 2.19 M | $9.72 M | 0.00% | 4.86% |
VANGUARD GROUP INC | 05/09/2025 | 1.95 M | $8.62 M | -2.68% | 4.32% |
POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 1.83 M | $8.11 M | 0.00% | 4.06% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 849.50 K | $3.76 M | 3.31% | 1.88% |
STATE STREET CORP | 05/15/2025 | 789.02 K | $3.50 M | -39.97% | 1.75% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 693.69 K | $3.07 M | 0.00% | 1.54% |
D. E. SHAW & CO., INC. | 05/15/2025 | 549.67 K | $2.44 M | -10.64% | 1.22% |
MORGAN STANLEY | 05/15/2025 | 500.16 K | $2.22 M | 55.91% | 1.11% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 466.62 K | $2.07 M | 1,216.39% | 1.03% |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 441.93 K | $1.96 M | -41.57% | 0.98% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 418.55 K | $1.86 M | -9.65% | 0.93% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 349.98 K | $1.55 M | 0.00% | 0.78% |
NORTHERN TRUST CORP | 05/13/2025 | 327.90 K | $1.45 M | -8.72% | 0.73% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 282.32 K | $1.25 M | 122.02% | 0.63% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 277.61 K | $1.23 M | -2.44% | 0.62% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 256.71 K | $1.14 M | 95.07% | 0.57% |
JPMORGAN CHASE & CO | 05/12/2025 | 247.44 K | $1.10 M | 153.37% | 0.55% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 237.51 K | $1.05 M | 58.68% | 0.53% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 204.05 K | $903.95 K | 53.12% | 0.45% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 201.78 K | $893.87 K | -7.94% | 0.45% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 164.79 K | $730.01 K | 869.34% | 0.37% |
05/16/2025 | 155.53 K | $688.99 K | 0.00% | 0.34% | |
CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 155.52 K | $688.96 K | 223.93% | 0.34% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 154.79 K | $685.70 K | 75.22% | 0.34% |
CITADEL ADVISORS LLC | 05/15/2025 | 153.96 K | $682.02 K | -30.62% | 0.34% |
FEDERATED HERMES, INC. | 05/08/2025 | 153.45 K | $679.80 K | 245.04% | 0.34% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 143.30 K | $634.82 K | 93.91% | 0.32% |
STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 131.16 K | $581.04 K | 100.00% | 0.29% |
SQUAREPOINT OPS LLC | 05/15/2025 | 128.53 K | $569.38 K | 24.82% | 0.29% |
05/12/2025 | 112.48 K | $498.30 K | 100.00% | 0.25% | |
RICE HALL JAMES & ASSOCIATES, LLC | 05/01/2025 | 103.64 K | $459.13 K | -4.52% | 0.23% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 95.50 K | $423.07 K | 1,859.42% | 0.21% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 92.47 K | $409.66 K | 0.03% | 0.21% |
UBS GROUP AG | 05/13/2025 | 91.58 K | $405.68 K | 135.22% | 0.20% |
XTX TOPCO LTD | 05/08/2025 | 91.45 K | $405.14 K | 340.36% | 0.20% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 60.66 K | $268.72 K | 112.92% | 0.13% |
WESBANCO BANK INC | 04/14/2025 | 55.00 K | $243.65 K | 100.00% | 0.12% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 54.78 K | $242.68 K | 0.00% | 0.12% |
RHUMBLINE ADVISERS | 05/29/2025 | 53.91 K | $238.81 K | 4.78% | 0.12% |
BARCLAYS PLC | 05/15/2025 | 46.76 K | $207.00 K | -38.36% | 0.10% |
SAPIENT CAPITAL LLC | 04/15/2025 | 43.70 K | $193.59 K | 0.00% | 0.10% |
STRS OHIO | 05/28/2025 | 43.40 K | $192.26 K | 0.00% | 0.10% |
QUEST PARTNERS LLC | 05/14/2025 | 38.93 K | $172.44 K | 43.45% | 0.09% |
CITADEL ADVISORS LLC | 05/15/2025 | 38.40 K | $170.11 K | 585.71% | 0.09% |
JUMP FINANCIAL, LLC | 05/14/2025 | 38.08 K | $168.69 K | 14.08% | 0.08% |
VIRTUS INVESTMENT ADVISERS, INC. | 05/15/2025 | 36.75 K | $162.81 K | 100.00% | 0.08% |
Y-mAbs Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 139 institutional investors and hedge funds held shares of Y-mAbs Therapeutics, Inc.. The most heavily invested institutionals were:
Paradigm Biocapital Advisors LP: 4.24 M
BlackRock, Inc.: 2.9 M
Caligan Partners LP: 2.34 M
Sofinnova Investments, Inc.: 2.19 M
VANGUARD GROUP INC: 1.95 M
Polar Capital Holdings Plc: 1.83 M
63.84% of Y-mAbs Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.25 M shares in the last 24 months. This purchase volume represents approximately $137.47 M in transactions.